“Dermatologic Immune-Related Adverse Events With Immune Checkpoint Inhibitors”. Canadian Dermatology Today 3, no. 3 (September 1, 2022): 40–46. Accessed March 19, 2026. https://canadiandermatologytoday.com/article/view/3-3-jfri.